MR编号 | DE/V/0241/001 |
---|
药品名称 | Zylexis |
---|
活性成分 | - parapoxvirus ovis 230.0 IFN/ml
|
---|
剂型 | Suspension for injection |
---|
上市许可持有人 | Pfizer Limited
Sandwich, Kent
CT13 9NJ
United Kingdom |
---|
参考成员国 - 产品名称 | Germany (DE) |
---|
互认成员国 - 产品名称 | - Denmark (DK)
Zylexis - Belgium (BE)
- Netherlands (NL)
Zylexis - Luxembourg (LU)
- United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Austria (AT)
- France (FR)
ZYLEXIS - Spain (ES)
- Portugal (PT)
- Italy (IT)
- Greece (GR)
- Sweden (SE)
- Norway (NO)
- Finland (FI)
- Latvia (LV)
- Lithuania (LT)
- Estonia (EE)
- Hungary (HU)
- Bulgaria (BG)
- Cyprus (CY)
- Romania (RO)
- Slovenia (SI)
ZYLEXIS
|
---|
许可日期 | 2007/06/22 |
---|
最近更新日期 | 2015/01/15 |
---|
药物ATC编码 | - QL03AX Other immunostimulants
|
---|
申请类型 | - TypeLevel1:[not specified]
- TypeLevel2:[not specified]
- TypeLevel3:Full dossier - art 12.3 Dir 2001/82/EC
- TypeLevel4:[not specified]
- TypeLevel5:[not specified]
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|